Home > Imaging, Diagnostics, and Therapeutics

Imaging, Diagnostics, and Therapeutics

 Imaging, Diagnostics, and Therapeutics Member Directory

ccsgexperimentalprogramThe Imaging, Diagnostics, and Therapeutics (IDT) program is a Cancer Center Support Grant (CCSG) program specifically organized to facilitate the development and validation of imaging, diagnostics, and therapeutic approaches for cancer applications. The IDT program draws from resources within Huntsman Cancer Institute (HCI) and leverages the existing strengths of the University of Utah in genetics, pharmaceutics, and imaging. Program membership, scientific expertise and interests, and goals are specifically aligned with the vision of making individualized oncology a reality. IDT program goals include the following:

  • Provide new approaches to individualized cancer diagnosis and therapy by developing new imaging techniques, diagnostics, and therapeutics, including image-guided and targeted drug delivery systems
  • Foster bidirectional translation of discoveries between the laboratory and the clinic by developing collaborations and scientific synergy among Cancer Center Program members
  • Better understand unmet clinical needs in cancer through collaboration and interaction with HCI Multidisciplinary Disease Groups
  • Advance theoretical and preclinical projects toward human applications in collaborative research projects
  • Develop and execute investigator-initiated imaging, diagnostic, and therapeutic clinical trials to establish new treatments for patients

The expertise of its members, from various departments from the colleges of Science, Pharmacy, Medicine, and Engineering, provides for truly cross-disciplinary research in cancer.

The IDT program has been organized into three thematic areas based on the membership's scientific interests and expertise and the vision of the program and Cancer Center as a whole.

Imaging: use of molecular imaging and image-guided therapy to improve diagnosis, therapy, and clinical careidtgraphic1

Diagnostics: development of novel diagnostic strategies for cancer characterization to improve therapies and to provide prognostic information to improve clinical care

Therapeutics: development of novel drugs and drug delivery systems, involving preclinical development, pharmacology, and clinical trials, both sponsored and investigator-initiated

The three thematic areas of scientific interest and expertise in the IDT program facilitate linking basic science to clinical oncology with the resulting outcome of a significant programmatic interest in investigator-initiated trials for imaging, diagnostics, and therapeutics. The program structure also facilitates the use of CCSG Shared Resources to improve the quality of cancer-related research and clinical trials performed by IDT program members.

The Imaging, Diagnostics, and Therapeutics Program currently receives approximately $9.1 million per year of direct research support from the National Institutes of Health, the National Science Foundation, and other funding agencies, with 36% coming from the National Cancer Institute. Cancer-focused articles published between 2003 and 2009 total 466, of which 15% are inter-programmatic and 17% are intra-programmatic publications.

 

Sunil Sharma, MD                John M. Hoffman, MD
Co-Leader                             Co-Leader

sharma s biohoffman j bio 

HCI, Room 3380                  HCI, Room 2121
801-587-5597                      801-587-4064


IDT Membership Directory



A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A


 

  • Agarwal, Neeraj

    Department: Medicine; Division of Oncology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 585-0255
    Research Interest: Prostate and kidney cancers

  • Akerley, Wallace

    Department: Medicine; Division of Oncology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 585-3453
    Research Interest: Experimental therapeutics, clinical trials in oncology, lung cancer and melanoma

  • Andtbacka, Robert

    Department: Surgery
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 587-4499
    Research Interest: New modalities for the detection of sentinel lymph nodes in patients with melanoma and breast cancer

Top | Next


 

B


  • Bae, You Han

    Department: Pharmaceutics and Pharmaceutical Chemistry
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 585-1518
    Research Interest: Anticancer drug carrier design targeting MDR

  • Barnette, Phillip

    Department: Pediatrics; Division of Pediatric Hematology/Oncology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 585-5543
    Research Interest: Oncology trials in pediatric patients

  • Bearss, David

    Department: Oncological Sciences
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 587-4561
    Research Interest: Use of computational approaches to modeling protein-small molecule interactions to discover potential drug candidates and algorithm development for developing models to predict ADME characteristics of small molecules for use in drug discovery

  • Bernard, Philip

    Department: Pathology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 581-5353
    Research Interest: Molecular diagnostics of solid and soft tumors

  • Bild, Andrea

    Department: Pharmacology and Toxicology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 581-6353
    Research Interest: Signal transduction in tumor initiation and metastasis

Previous | Top | Next


 

C


Previous | Top | Next


 

D


 

  • DiBella, Edward

    Department: Radiology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 585-5543
    Research Interest: Mathematical models to quantify physiological parameters of cancer from MRI

Previous | Top | Next


 

E


Previous | Top | Next


 

F

  • Firpo, Matt

    Department: Surgery
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 587-9049
    Research Interest: Pancreatic cancer

  • Furgeson, Darin

    Department: Pharmaceutics and Pharmaceutical Chemistry 
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 581-7271
    Research Interest: Cleaning dirty tumor margins with thermo-targeted chemotherapy and microwave ablation; Recominant siRNA delivery vehicles to treat neuro-disease across the blood brain barrier


Previous | Top | Next


 

G


  • Gaffney, David

    Department: Radiation Oncology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 581-2396
    Research Interest: Radiotherapy for gynecology, breast, and lymphoma

  • Garrido-Laguna, Ignacio
  • Department: Medicine; Division of Oncology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: 801-585-1435
    Research Interest: Pancreatic cancer, drugs targeting stroma, EMT

  • Ghandehari, Hamid

    Department: Pharmaceutics and Pharmaceutical Chemistry
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 587-1566
    Research Interest: Design of new polymers for gene therapy of head and neck cancer

  • Grissom, Charles

    Department: Biochemistry
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 581-4153
    Research Interest: Cancer drug development, tumor imaging, lymph node imaging

Previous | Top | Next


 

H


  • Hoffman, John

    Department: Radiology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 587-4064
    Research Interest: Molecular imaging, particularly positron emission tomography (PET) imaging in cancer patients

Previous | Top | Next


 

I


Previous | Top | Next


 

J


  • Janát-Amsbury, Margit

    Department: Obstetrics/Gynecology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 213-2248
    Research Interest: The development of novel, mainly nanotechnology-based systems for clkinical cancer therapy

  • Jensen, Randy

    Department: Neurosurgery
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 581-6908
    Research Interest: Brain tumor angiogenesis and hypxoxia


Previous | Top | Next


 

K


  • Kadrmas, Dan

    Department: Radiology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 581-5937
    Research Interest: Biomaterials and drug delivery, positron emission tomography (PET) imaging

  • Kim, Sung Wan

    Department: Pharmaceutics and Pharmaceutical Chemistry
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 581-6801
    Research Interest: Medical polymers and drug delivery, angiogenesis targeting

  • Kopecek, Jindrich

    Department: Pharmaceutics and Pharmaceutical Chemistry
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 581-7211
    Research Interest: Biomaterials and drug delivery

Previous | Top | Next


 

L


Previous | Top | Next


 

M

 

  • McGreevy, James

    Department: Surgery
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 581-4488
    Research Interest: Identification of novel tumor markers

 

  • Morrell, Glen

    Department: Radiology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 581-7553
    Research Interest: Breast MRI and MRI characterization of breast cancer

  • Morton, Kathryn

    Department: Radiology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 585-9068
    Research Interest: Molecular imaging, PET scanning in cancer

  • Mulvihill, Sean

    Department: Surgery
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 581-7304
    Research Interest: Biology of pancreatic cancer

Previous | Top | Next


 

N

O

 

Previous | Top | Next


 

P

 

  • Parker, Dennis

    Department: Radiology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 581-8654
    Research Interest: MR angiography, MRI scanner design, MRI guided thermal ablation of tumors

  • Porter, Marc

    Department: Pathology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 587-8654
    Research Interest: Innovations in nanotechnology for the creation of ultrasensitive and real-time assays for the detection of cancer markers including PSA and pancreatic cancer

  • Prchal, Josef

    Department: Hematology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 585-3229
    Research Interest: Germ line and somatic mutations leading to disease hematopoiesis, identifying the molecular basis of these disorders

  • Pulsipher, Michael

    Department: Pediatrics; Division of Pediatric Hematology/Oncology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 588-2680
    Research Interest: Reduced intensity allogeneic transplantation, transplantation of pediatric ALL, hematopoietic stem cell donor safety

Previous | Top | Next


 

Q

 

Previous | Top | Next


 

R

 

  • Randall, R. Lor

    Department: Orthopaedics
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 581-7601
    Research Interest: Genetics of sarcoma

  • Rapoport, Natalya

    Department: Bioengineering
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 581-8990
    Research Interest: Combined ultrasonography and ultrasound-mediated chemotherapy of drug-sensitive and multidrug resistant tumors

Previous | Top | Next


 

S

 

  • Scaife, Courtney

    Department: Surgery
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 585-6911
    Research Interest: Pancreas cancer modeling and mechanisms of metastases

  • Shami, Paul

    Department: Medicine; Division of Hematology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 585-0255
    Research Interest: Nitric oxide and hematopoietic cell biology, acute leukemia and myelodysplatic syndromes

  • Sharma, Sunil

    Department: Medicine; Division of Oncology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 587-5597
    Research Interest: Gastrointestinal cancers (colon, pancreatic, esophageal, rectal, liver), mesothelioma, and rare tumors (carcinoid, neuroendocrine tumors, and carcinomas of unknown primarys)

  • Shrieve, Dennis

    Department: Radiation Oncology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 581-8793
    Research Interest: Assessment of the intrinsic radiosensitivity of human tumors, mechanisms of intrinsic cellular resistance to radiation and chemotherapy and combined chemotherapy/radiotherapy, clinical trials in brain tumors

Previous | Top | Next


 

T

 

Previous | Top | Next


 

U

 

Previous | Top | Next


 

V

 

Previous | Top | Next


 

W

 

  • Ward, John

    Department: Medicine; Division of Oncology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 585-0255
    Research Interest: Breast cancer management

  • Werner, Theresa

    Department: Medicine; Division of Oncology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 585-0255
    Research Interest: High risk breast/ovarian cancer

 

Previous | Top | Next


 

X


Previous | Top | Next


 

Y

 

Previous | Top | Next


 

Z


  • Zangari, Maurizio

    Department: Medicine; Division of Hematology
    E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
    Phone: (801) 213-2281
    Research Interest: New treatments for patients with multiple myeloma, tandem autologous transplantation for treatment of multiple myeloma, personalized treatment strategies for the treatment of myeloma

Previous | Top

 

 

Cancer Types and Topics

clccancerquestions
HCI NEWS >>>  SIGN UP TODAY
for our e-newsletter
 
youtube_icon